Insulin resistance with elevated HbA1c.
Original indication for semaglutide (Ozempic) and tirzepatide (Mounjaro).
GLP-1 agonists improve glycemic control and offer cardiovascular benefit in patients with established disease.
Five minutes. Free. No pressure.